The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute

Interventions designed to limit the spread of coronavirus disease 2019 (COVID-19) are having profound effects on the delivery of health care, but data showing the impact on oncology clinical trial enrollment, treatment, and monitoring are limited. We prospectively tracked relevant data from oncology...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Natl Cancer Inst
Päätekijät: Tolaney, Sara M, Lydon, Christine A, Li, Tianyu, Dai, Jiale, Standring, Andrea, Legor, Kristen A, Caparrotta, Caryn M, Schenker, Matthew P, Glazer, Daniel I, Tayob, Nabihah, DuBois, Steven G, Meyerhardt, Jeffrey A, Taplin, Mary-Ellen, Johnson, Bruce E
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Commentaries
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543498/
https://ncbi.nlm.nih.gov/pubmed/32959883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa144
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia